Yingying Kang

Efficacy and safety of cyclophosphamide in anthracycline- and taxane-based neoadjuvant chemotherapy in breast cancer: a meta-analysis.

P. Yuan, Yingying Kang, Y. Si, 2021, Gland surgery.

Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer

Dong Liu, F. Du, Bing-he Xu, 2022, Breast Cancer Research and Treatment.

The screening value of mammography for breast cancer : an overview of 22 systematic reviews with evidence mapping (Preprint)

Jie He, Wanqing Chen, Ni Li, 2020 .

The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer

P. Yuan, J. Ju, Yingying Kang, 2021, Frontiers in Oncology.

Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study

B. Xu, Yun-Yun Zhang, P. Yuan, 2022, Cancer medicine.

Prognostic factors and adjuvant systemic therapy for patients with HER2-positive T1N0 breast cancer: evidence from a real-world study with long-term follow-up

F. Du, P. Yuan, J. Ju, 2022, Breast Cancer Research and Treatment.